joint venture

Latest Headlines

Latest Headlines

Africa's growing market attracts Hikma to Ethiopia

South Africa has a well-established pharmaceutical industry, and North Africa is attracting more attention from Western drugmakers. But many countries in between have limited infrastructure or challenging political situations. Figuring out which have the potential to be emerging markets worth investing in can be a challenge. Jordan-based Hikma sees potential in Ethiopia.

GSK planning joint venture to tap into Chinese vaccine demand

Despite the negative attention of the ongoing corruption probe, GlaxoSmithKline is still pressing ahead with its Chinese expansion plans, and its vaccine unit is a major part of the strategy.

Sights set on Asia, Amgen sets up JV development deal with Astellas

Just a few months after Amgen execs lamented a big Asian gap in their global strategy, the Big Biotech company has joined hands with Astellas to set up a new joint venture in Japan. Amgen is contributing 5 experimental-stage programs to the JV, including their late-stage anti-PCSK9 program for the cholesterol drug AMG-145.

Malaysia's Pharmaniaga slates drug plant in Saudi Arabia

Saudi Arabia is drawing yet more interest from companies that see potential from manufacturing drugs there. The Indonesian company Pharmaniaga is teaming with Saudi Arabia-based Modern Healthcare Solutions to build a drug manufacturing plant.

At long last, Sony and Olympus launch medical device joint venture

After indefinitely suspending their plans over a Chinese regulatory snag, Sony and Olympus are finally kicking off their long-planned medical device joint venture, planning to sell endoscopes and imaging technologies around the world.

Bausch + Lomb snatches up ophthalmology laser startup

Bausch + Lomb said it will buy the remaining shares of ophthalmology laser company Technolas Perfect Vision, a company it initially established through a joint venture with 2010 Perfect Vision AG back in 2009.

Report: Biosimilars team at Teva/Lonza slams the brakes on Rituxan knockoff

Three years after Teva and Switzerland's Lonza joined forces to create a new joint venture to develop a few blockbuster biosimilars, one of their lead programs has hit an unexpected roadblock. The Israeli  newspaper Haaretz reports that Teva has suspended its Phase III study of a biosimilar of Rituxan, one of the world's top-selling drugs from Roche.

Everist Genomics aligns with India's Manipal Group

The company has created a joint venture with Manipal Group in India to tap that market primarily for sales of its mobile monitoring devices. 

Dr. Reddy's nears launch of Fujifilm venture, CFO says

After announcing the tie-up almost a year ago, India's Dr. Reddy's Laboratories ($RDY) finally expects to ink a joint venture agreement with Fujifilm.

GlaxoSmithKline, Daiichi Sankyo join forces to sell vaccines in Japan

GlaxoSmithKline ($GSK) and Daiichi Sankyo ($D4S.BE) will jointly invest about $1.2 million and pool their vaccine operations into a 50/50 joint venture that they expect will be largest vaccine company in Japan.